세계의 응급 피임약 시장 (2023~2027) : 소매점, 온라인 스토어

■ 영문 제목 : Global Emergency Contraceptive Pills Market 2023-2027

Technavio 회사가 출판한 조사자료로, 코드는 IRTNTR70846-23 입니다.■ 상품코드 : IRTNTR70846-23
■ 조사/발행회사 : Technavio
■ 발행일 : 2022년 12월
■ 페이지수 : 약120
■ 작성언어 : 영문
■ 보고서 형태 : PDF
■ 납품 방식 : E메일 (24시간 이내)
■ 조사대상 지역 : 북미, 유럽, 아시아, 기타 지역
■ 산업 분야 : 의약품
■ 판매가격 / 옵션 (부가세 10% 별도)
Single User (1명 열람용)USD2,500 ⇒환산₩3,375,000견적의뢰/주문/질문
Enterprise License (동일기업내 공유가능)USD4,000 ⇒환산₩5,400,000견적의뢰/주문/질문
가격옵션 설명
- 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다.
- 지불방법은 계좌이체/무통장입금 또는 카드결제입니다.
Technavio사는 세계의 응급 피임약 시장 규모가 2022년부터 2027년까지 연평균 4.83% 성장하여, 258.7백만 달러에 달할 것으로 예측하고 있습니다. 본 조사 보고서는 세계의 응급 피임약 시장을 조사 대상으로 하여, 개요, 시장 현황, 시장 규모 예측, 과거 시장 규모, 파이브 포스 분석, 유통 채널별 (소매점, 온라인 스토어) 분석, 종류별 (배합제, 프로게스테론 제제) 분석, 고객 현황, 지역별 현황 (북미, 유럽, 아시아 태평양, 기타 지역, 미국, 중국, 독일, 프랑스, ​​일본) 분석, 추진 요인/과제/동향, 기업 현황, 기업 분석 등의 항목을 게재하고 있습니다. 또한 본 자료는 AbbVie Inc., Afaxys Pharma LLC, Bayer AG, Combe Inc., Foundation Consumer Healthcare LLC, Gedeon Richter Plc, HLL Lifecare Ltd., Knoll Healthcare Pvt. Ltd., Laboratoire HRA Pharma SAS, Lupin Ltd., Mankind Pharma Ltd., Morepen Laboratories Ltd., Perrigo Co. Plc, Pfizer Inc., Piramal Enterprises Ltd., Sun Pharmaceutical Industries Ltd., Syzygy Healthcare LLC, Teva Pharmaceutical Industries Ltd. 등의 기업 정보를 포함하고 있습니다.

・개요
・시장 현황
・시장 규모 예측
・과거 시장 규모
・파이브 포스 분석
・세계의 응급 피임약 시장 규모 : 유통 채널별
- 소매점 채널의 시장 규모
- 온라인 스토어 채널의 시장 규모
・세계의 응급 피임약 시장 규모 : 종류별
- 배합제의 시장 규모
- 프로게스테론 제제의 시장 규모
・고객 현황
・세계의 응급 피임약 시장 규모 : 지역별
- 북미의 응급 피임약 시장 규모
- 유럽의 응급 피임약 시장 규모
- 아시아 태평양의 응급 피임약 시장 규모
- 기타 지역의 응급 피임약 시장 규모
- 미국의 응급 피임약 시장 규모
- 중국의 응급 피임약 시장 규모
- 독일의 응급 피임약 시장 규모
- 프랑스의 응급 피임약 시장 규모
- 일본의 응급 피임약 시장 규모
・추진 요인/과제/동향
・기업 현황
・기업 분석

Technavio 사는 이익, 가격, 경쟁, 프로모션과 같은 주요 매개 변수를 분석하여, 다수의 소스로부터 데이터를 조사, 통합 및 합산하여 시장에 대한 상세하고 종합적인 결과를 제공합니다. 또한, 주요 산업의 영향 요인을 분석하여 시장의 다양한 관점을 제시합니다. 제시된 데이터는 포괄적이고 신뢰할 수 있으며, 1차 및 2차에 걸친 광범위한 조사 결과입니다. 덧붙여 Technavio 사의 시장 조사 보고서는 정확한 시장 성장을 예측하기 위해, 정성적 및 정량적 조사를 사용하여, 명확한 경쟁 현황과 상세한 벤더 선택 방법 및 분석을 제공합니다.
■ 보고서 개요

Technavio Announces the Publication of its Research Report – Global Emergency Contraceptive Pills Market 2023-2027Technavio recognizes the following companies as the key players in the global emergency contraceptive pills market: AbbVie Inc., Afaxys Pharma LLC, Bayer AG, Combe Inc., Foundation Consumer Healthcare LLC, Gedeon Richter Plc, HLL Lifecare Ltd., Knoll Healthcare Pvt. Ltd., Laboratoire HRA Pharma SAS, Lupin Ltd., Mankind Pharma Ltd., Morepen Laboratories Ltd., Perrigo Co. Plc, Pfizer Inc., Piramal Enterprises Ltd., Sun Pharmaceutical Industries Ltd., Syzygy Healthcare LLC, and Teva Pharmaceutical Industries Ltd.
Commenting on the report, an analyst from Technavio said: “The latest trend gaining momentum in the market is importance of family planning.”
According to the report, one of the major drivers for this market is the rise in number of initiatives to create awareness.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors. For further information on this report, please visit- www.technavio.com/report/emergency-contraceptive-pills-market-industry-analysis
Technavio, the market research platform of Infiniti Research Ltd., publishes periodic market research reports on niche and emerging technologies. For more information on our market research, please visit- www.technavio.com/industries/personal-products
Follow us on Twitter @Technavio

■ 보고서 목차

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary – Chart on Market Overview
o Exhibit 02: Executive Summary – Data Table on Market Overview
o Exhibit 03: Executive Summary – Chart on Global Market Characteristics
o Exhibit 04: Executive Summary – Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary – Chart on Market Segmentation by Distribution Channel
o Exhibit 06: Executive Summary – Chart on Market Segmentation by Type
o Exhibit 07: Executive Summary – Chart on Incremental Growth
o Exhibit 08: Executive Summary – Data Table on Incremental Growth
o Exhibit 09: Executive Summary – Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2022
o 3.4 Market outlook: Forecast for 2022-2027
o Exhibit 14: Chart on Global – Market size and forecast 2022-2027 ($ million)
o Exhibit 15: Data Table on Global – Market size and forecast 2022-2027 ($ million)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
• 4 Historic Market Size
o 4.1 Global emergency contraceptive pills market 2017 – 2021
o Exhibit 18: Historic Market Size – Data Table on Global emergency contraceptive pills market 2017 – 2021 ($ million)
o 4.2 Distribution channel Segment Analysis 2017 – 2021
o Exhibit 19: Historic Market Size – Distribution channel Segment 2017 – 2021 ($ million)
o 4.3 Type Segment Analysis 2017 – 2021
o Exhibit 20: Historic Market Size – Type Segment 2017 – 2021 ($ million)
o 4.4 Geography Segment Analysis 2017 – 2021
o Exhibit 21: Historic Market Size – Geography Segment 2017 – 2021 ($ million)
o 4.5 Country Segment Analysis 2017 – 2021
o Exhibit 22: Historic Market Size – Country Segment 2017 – 2021 ($ million)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis – Comparison between 2022 and 2027
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027
o 5.7 Market condition
o Exhibit 29: Chart on Market condition – Five forces 2022 and 2027
• 6 Market Segmentation by Distribution Channel
o 6.1 Market segments
o Exhibit 30: Chart on Distribution Channel – Market share 2022-2027 (%)
o Exhibit 31: Data Table on Distribution Channel – Market share 2022-2027 (%)
o 6.2 Comparison by Distribution Channel
o Exhibit 32: Chart on Comparison by Distribution Channel
o Exhibit 33: Data Table on Comparison by Distribution Channel
o 6.3 Retail stores – Market size and forecast 2022-2027
o Exhibit 34: Chart on Retail stores – Market size and forecast 2022-2027 ($ million)
o Exhibit 35: Data Table on Retail stores – Market size and forecast 2022-2027 ($ million)
o Exhibit 36: Chart on Retail stores – Year-over-year growth 2022-2027 (%)
o Exhibit 37: Data Table on Retail stores – Year-over-year growth 2022-2027 (%)
o 6.4 Online stores – Market size and forecast 2022-2027
o Exhibit 38: Chart on Online stores – Market size and forecast 2022-2027 ($ million)
o Exhibit 39: Data Table on Online stores – Market size and forecast 2022-2027 ($ million)
o Exhibit 40: Chart on Online stores – Year-over-year growth 2022-2027 (%)
o Exhibit 41: Data Table on Online stores – Year-over-year growth 2022-2027 (%)
o 6.5 Market opportunity by Distribution Channel
o Exhibit 42: Market opportunity by Distribution Channel ($ million)
• 7 Market Segmentation by Type
o 7.1 Market segments
o Exhibit 43: Chart on Type – Market share 2022-2027 (%)
o Exhibit 44: Data Table on Type – Market share 2022-2027 (%)
o 7.2 Comparison by Type
o Exhibit 45: Chart on Comparison by Type
o Exhibit 46: Data Table on Comparison by Type
o 7.3 Combination pills – Market size and forecast 2022-2027
o Exhibit 47: Chart on Combination pills – Market size and forecast 2022-2027 ($ million)
o Exhibit 48: Data Table on Combination pills – Market size and forecast 2022-2027 ($ million)
o Exhibit 49: Chart on Combination pills – Year-over-year growth 2022-2027 (%)
o Exhibit 50: Data Table on Combination pills – Year-over-year growth 2022-2027 (%)
o 7.4 Progesterone pills – Market size and forecast 2022-2027
o Exhibit 51: Chart on Progesterone pills – Market size and forecast 2022-2027 ($ million)
o Exhibit 52: Data Table on Progesterone pills – Market size and forecast 2022-2027 ($ million)
o Exhibit 53: Chart on Progesterone pills – Year-over-year growth 2022-2027 (%)
o Exhibit 54: Data Table on Progesterone pills – Year-over-year growth 2022-2027 (%)
o 7.5 Market opportunity by Type
o Exhibit 55: Market opportunity by Type ($ million)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 56: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 57: Chart on Market share By Geographical Landscape 2022-2027 (%)
o Exhibit 58: Data Table on Market share By Geographical Landscape 2022-2027 (%)
o 9.2 Geographic comparison
o Exhibit 59: Chart on Geographic comparison
o Exhibit 60: Data Table on Geographic comparison
o 9.3 North America – Market size and forecast 2022-2027
o Exhibit 61: Chart on North America – Market size and forecast 2022-2027 ($ million)
o Exhibit 62: Data Table on North America – Market size and forecast 2022-2027 ($ million)
o Exhibit 63: Chart on North America – Year-over-year growth 2022-2027 (%)
o Exhibit 64: Data Table on North America – Year-over-year growth 2022-2027 (%)
o 9.4 Europe – Market size and forecast 2022-2027
o Exhibit 65: Chart on Europe – Market size and forecast 2022-2027 ($ million)
o Exhibit 66: Data Table on Europe – Market size and forecast 2022-2027 ($ million)
o Exhibit 67: Chart on Europe – Year-over-year growth 2022-2027 (%)
o Exhibit 68: Data Table on Europe – Year-over-year growth 2022-2027 (%)
o 9.5 Asia – Market size and forecast 2022-2027
o Exhibit 69: Chart on Asia – Market size and forecast 2022-2027 ($ million)
o Exhibit 70: Data Table on Asia – Market size and forecast 2022-2027 ($ million)
o Exhibit 71: Chart on Asia – Year-over-year growth 2022-2027 (%)
o Exhibit 72: Data Table on Asia – Year-over-year growth 2022-2027 (%)
o 9.6 Rest of World (ROW) – Market size and forecast 2022-2027
o Exhibit 73: Chart on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
o Exhibit 74: Data Table on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
o Exhibit 75: Chart on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
o Exhibit 76: Data Table on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
o 9.7 US – Market size and forecast 2022-2027
o Exhibit 77: Chart on US – Market size and forecast 2022-2027 ($ million)
o Exhibit 78: Data Table on US – Market size and forecast 2022-2027 ($ million)
o Exhibit 79: Chart on US – Year-over-year growth 2022-2027 (%)
o Exhibit 80: Data Table on US – Year-over-year growth 2022-2027 (%)
o 9.8 China – Market size and forecast 2022-2027
o Exhibit 81: Chart on China – Market size and forecast 2022-2027 ($ million)
o Exhibit 82: Data Table on China – Market size and forecast 2022-2027 ($ million)
o Exhibit 83: Chart on China – Year-over-year growth 2022-2027 (%)
o Exhibit 84: Data Table on China – Year-over-year growth 2022-2027 (%)
o 9.9 Germany – Market size and forecast 2022-2027
o Exhibit 85: Chart on Germany – Market size and forecast 2022-2027 ($ million)
o Exhibit 86: Data Table on Germany – Market size and forecast 2022-2027 ($ million)
o Exhibit 87: Chart on Germany – Year-over-year growth 2022-2027 (%)
o Exhibit 88: Data Table on Germany – Year-over-year growth 2022-2027 (%)
o 9.10 France – Market size and forecast 2022-2027
o Exhibit 89: Chart on France – Market size and forecast 2022-2027 ($ million)
o Exhibit 90: Data Table on France – Market size and forecast 2022-2027 ($ million)
o Exhibit 91: Chart on France – Year-over-year growth 2022-2027 (%)
o Exhibit 92: Data Table on France – Year-over-year growth 2022-2027 (%)
o 9.11 Japan – Market size and forecast 2022-2027
o Exhibit 93: Chart on Japan – Market size and forecast 2022-2027 ($ million)
o Exhibit 94: Data Table on Japan – Market size and forecast 2022-2027 ($ million)
o Exhibit 95: Chart on Japan – Year-over-year growth 2022-2027 (%)
o Exhibit 96: Data Table on Japan – Year-over-year growth 2022-2027 (%)
o 9.12 Market opportunity By Geographical Landscape
o Exhibit 97: Market opportunity By Geographical Landscape ($ million)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 98: Impact of drivers and challenges in 2022 and 2027
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 99: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 100: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 101: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 102: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 103: Matrix on vendor position and classification
o 12.3 AbbVie Inc.
o Exhibit 104: AbbVie Inc. – Overview
o Exhibit 105: AbbVie Inc. – Product / Service
o Exhibit 106: AbbVie Inc. – Key news
o Exhibit 107: AbbVie Inc. – Key offerings
o 12.4 Afaxys Pharma LLC
o Exhibit 108: Afaxys Pharma LLC – Overview
o Exhibit 109: Afaxys Pharma LLC – Product / Service
o Exhibit 110: Afaxys Pharma LLC – Key offerings
o 12.5 Bayer AG
o Exhibit 111: Bayer AG – Overview
o Exhibit 112: Bayer AG – Business segments
o Exhibit 113: Bayer AG – Key news
o Exhibit 114: Bayer AG – Key offerings
o Exhibit 115: Bayer AG – Segment focus
o 12.6 Combe Inc.
o Exhibit 116: Combe Inc. – Overview
o Exhibit 117: Combe Inc. – Product / Service
o Exhibit 118: Combe Inc. – Key offerings
o 12.7 Foundation Consumer Healthcare LLC
o Exhibit 119: Foundation Consumer Healthcare LLC – Overview
o Exhibit 120: Foundation Consumer Healthcare LLC – Product / Service
o Exhibit 121: Foundation Consumer Healthcare LLC – Key offerings
o 12.8 Gedeon Richter Plc
o Exhibit 122: Gedeon Richter Plc – Overview
o Exhibit 123: Gedeon Richter Plc – Business segments
o Exhibit 124: Gedeon Richter Plc – Key news
o Exhibit 125: Gedeon Richter Plc – Key offerings
o Exhibit 126: Gedeon Richter Plc – Segment focus
o 12.9 HLL Lifecare Ltd.
o Exhibit 127: HLL Lifecare Ltd. – Overview
o Exhibit 128: HLL Lifecare Ltd. – Product / Service
o Exhibit 129: HLL Lifecare Ltd. – Key offerings
o 12.10 Laboratoire HRA Pharma SAS
o Exhibit 130: Laboratoire HRA Pharma SAS – Overview
o Exhibit 131: Laboratoire HRA Pharma SAS – Product / Service
o Exhibit 132: Laboratoire HRA Pharma SAS – Key offerings
o 12.11 Lupin Ltd.
o Exhibit 133: Lupin Ltd. – Overview
o Exhibit 134: Lupin Ltd. – Product / Service
o Exhibit 135: Lupin Ltd. – Key news
o Exhibit 136: Lupin Ltd. – Key offerings
o 12.12 Mankind Pharma Ltd.
o Exhibit 137: Mankind Pharma Ltd. – Overview
o Exhibit 138: Mankind Pharma Ltd. – Product / Service
o Exhibit 139: Mankind Pharma Ltd. – Key offerings
o 12.13 Perrigo Co. Plc
o Exhibit 140: Perrigo Co. Plc – Overview
o Exhibit 141: Perrigo Co. Plc – Business segments
o Exhibit 142: Perrigo Co. Plc – Key news
o Exhibit 143: Perrigo Co. Plc – Key offerings
o Exhibit 144: Perrigo Co. Plc – Segment focus
o 12.14 Pfizer Inc.
o Exhibit 145: Pfizer Inc. – Overview
o Exhibit 146: Pfizer Inc. – Product / Service
o Exhibit 147: Pfizer Inc. – Key news
o Exhibit 148: Pfizer Inc. – Key offerings
o 12.15 Piramal Enterprises Ltd.
o Exhibit 149: Piramal Enterprises Ltd. – Overview
o Exhibit 150: Piramal Enterprises Ltd. – Business segments
o Exhibit 151: Piramal Enterprises Ltd. – Key offerings
o Exhibit 152: Piramal Enterprises Ltd. – Segment focus
o 12.16 Sun Pharmaceutical Industries Ltd.
o Exhibit 153: Sun Pharmaceutical Industries Ltd. – Overview
o Exhibit 154: Sun Pharmaceutical Industries Ltd. – Product / Service
o Exhibit 155: Sun Pharmaceutical Industries Ltd. – Key offerings
o 12.17 Syzygy Healthcare LLC
o Exhibit 156: Syzygy Healthcare LLC – Overview
o Exhibit 157: Syzygy Healthcare LLC – Product / Service
o Exhibit 158: Syzygy Healthcare LLC – Key offerings
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 159: Inclusions checklist
o Exhibit 160: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 161: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 162: Research methodology
o Exhibit 163: Validation techniques employed for market sizing
o Exhibit 164: Information sources
o 13.5 List of abbreviations
o Exhibit 165: List of abbreviations

Exhibits:
Exhibits1: Executive Summary – Chart on Market Overview
Exhibits2: Executive Summary – Data Table on Market Overview
Exhibits3: Executive Summary – Chart on Global Market Characteristics
Exhibits4: Executive Summary – Chart on Market By Geographical Landscape
Exhibits5: Executive Summary – Chart on Market Segmentation by Distribution Channel
Exhibits6: Executive Summary – Chart on Market Segmentation by Type
Exhibits7: Executive Summary – Chart on Incremental Growth
Exhibits8: Executive Summary – Data Table on Incremental Growth
Exhibits9: Executive Summary – Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global – Market size and forecast 2022-2027 ($ million)
Exhibits15: Data Table on Global – Market size and forecast 2022-2027 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size – Data Table on Global emergency contraceptive pills market 2017 – 2021 ($ million)
Exhibits19: Historic Market Size – Distribution channel Segment 2017 – 2021 ($ million)
Exhibits20: Historic Market Size – Type Segment 2017 – 2021 ($ million)
Exhibits21: Historic Market Size – Geography Segment 2017 – 2021 ($ million)
Exhibits22: Historic Market Size – Country Segment 2017 – 2021 ($ million)
Exhibits23: Five forces analysis – Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants – Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes – Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry – Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition – Five forces 2022 and 2027
Exhibits30: Chart on Distribution Channel – Market share 2022-2027 (%)
Exhibits31: Data Table on Distribution Channel – Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Distribution Channel
Exhibits33: Data Table on Comparison by Distribution Channel
Exhibits34: Chart on Retail stores – Market size and forecast 2022-2027 ($ million)
Exhibits35: Data Table on Retail stores – Market size and forecast 2022-2027 ($ million)
Exhibits36: Chart on Retail stores – Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Retail stores – Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Online stores – Market size and forecast 2022-2027 ($ million)
Exhibits39: Data Table on Online stores – Market size and forecast 2022-2027 ($ million)
Exhibits40: Chart on Online stores – Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Online stores – Year-over-year growth 2022-2027 (%)
Exhibits42: Market opportunity by Distribution Channel ($ million)
Exhibits43: Chart on Type – Market share 2022-2027 (%)
Exhibits44: Data Table on Type – Market share 2022-2027 (%)
Exhibits45: Chart on Comparison by Type
Exhibits46: Data Table on Comparison by Type
Exhibits47: Chart on Combination pills – Market size and forecast 2022-2027 ($ million)
Exhibits48: Data Table on Combination pills – Market size and forecast 2022-2027 ($ million)
Exhibits49: Chart on Combination pills – Year-over-year growth 2022-2027 (%)
Exhibits50: Data Table on Combination pills – Year-over-year growth 2022-2027 (%)
Exhibits51: Chart on Progesterone pills – Market size and forecast 2022-2027 ($ million)
Exhibits52: Data Table on Progesterone pills – Market size and forecast 2022-2027 ($ million)
Exhibits53: Chart on Progesterone pills – Year-over-year growth 2022-2027 (%)
Exhibits54: Data Table on Progesterone pills – Year-over-year growth 2022-2027 (%)
Exhibits55: Market opportunity by Type ($ million)
Exhibits56: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits57: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits58: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits59: Chart on Geographic comparison
Exhibits60: Data Table on Geographic comparison
Exhibits61: Chart on North America – Market size and forecast 2022-2027 ($ million)
Exhibits62: Data Table on North America – Market size and forecast 2022-2027 ($ million)
Exhibits63: Chart on North America – Year-over-year growth 2022-2027 (%)
Exhibits64: Data Table on North America – Year-over-year growth 2022-2027 (%)
Exhibits65: Chart on Europe – Market size and forecast 2022-2027 ($ million)
Exhibits66: Data Table on Europe – Market size and forecast 2022-2027 ($ million)
Exhibits67: Chart on Europe – Year-over-year growth 2022-2027 (%)
Exhibits68: Data Table on Europe – Year-over-year growth 2022-2027 (%)
Exhibits69: Chart on Asia – Market size and forecast 2022-2027 ($ million)
Exhibits70: Data Table on Asia – Market size and forecast 2022-2027 ($ million)
Exhibits71: Chart on Asia – Year-over-year growth 2022-2027 (%)
Exhibits72: Data Table on Asia – Year-over-year growth 2022-2027 (%)
Exhibits73: Chart on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
Exhibits74: Data Table on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
Exhibits75: Chart on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
Exhibits76: Data Table on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
Exhibits77: Chart on US – Market size and forecast 2022-2027 ($ million)
Exhibits78: Data Table on US – Market size and forecast 2022-2027 ($ million)
Exhibits79: Chart on US – Year-over-year growth 2022-2027 (%)
Exhibits80: Data Table on US – Year-over-year growth 2022-2027 (%)
Exhibits81: Chart on China – Market size and forecast 2022-2027 ($ million)
Exhibits82: Data Table on China – Market size and forecast 2022-2027 ($ million)
Exhibits83: Chart on China – Year-over-year growth 2022-2027 (%)
Exhibits84: Data Table on China – Year-over-year growth 2022-2027 (%)
Exhibits85: Chart on Germany – Market size and forecast 2022-2027 ($ million)
Exhibits86: Data Table on Germany – Market size and forecast 2022-2027 ($ million)
Exhibits87: Chart on Germany – Year-over-year growth 2022-2027 (%)
Exhibits88: Data Table on Germany – Year-over-year growth 2022-2027 (%)
Exhibits89: Chart on France – Market size and forecast 2022-2027 ($ million)
Exhibits90: Data Table on France – Market size and forecast 2022-2027 ($ million)
Exhibits91: Chart on France – Year-over-year growth 2022-2027 (%)
Exhibits92: Data Table on France – Year-over-year growth 2022-2027 (%)
Exhibits93: Chart on Japan – Market size and forecast 2022-2027 ($ million)
Exhibits94: Data Table on Japan – Market size and forecast 2022-2027 ($ million)
Exhibits95: Chart on Japan – Year-over-year growth 2022-2027 (%)
Exhibits96: Data Table on Japan – Year-over-year growth 2022-2027 (%)
Exhibits97: Market opportunity By Geographical Landscape ($ million)
Exhibits98: Impact of drivers and challenges in 2022 and 2027
Exhibits99: Overview on Criticality of inputs and Factors of differentiation
Exhibits100: Overview on factors of disruption
Exhibits101: Impact of key risks on business
Exhibits102: Vendors covered
Exhibits103: Matrix on vendor position and classification
Exhibits104: AbbVie Inc. – Overview
Exhibits105: AbbVie Inc. – Product / Service
Exhibits106: AbbVie Inc. – Key news
Exhibits107: AbbVie Inc. – Key offerings
Exhibits108: Afaxys Pharma LLC – Overview
Exhibits109: Afaxys Pharma LLC – Product / Service
Exhibits110: Afaxys Pharma LLC – Key offerings
Exhibits111: Bayer AG – Overview
Exhibits112: Bayer AG – Business segments
Exhibits113: Bayer AG – Key news
Exhibits114: Bayer AG – Key offerings
Exhibits115: Bayer AG – Segment focus
Exhibits116: Combe Inc. – Overview
Exhibits117: Combe Inc. – Product / Service
Exhibits118: Combe Inc. – Key offerings
Exhibits119: Foundation Consumer Healthcare LLC – Overview
Exhibits120: Foundation Consumer Healthcare LLC – Product / Service
Exhibits121: Foundation Consumer Healthcare LLC – Key offerings
Exhibits122: Gedeon Richter Plc – Overview
Exhibits123: Gedeon Richter Plc – Business segments
Exhibits124: Gedeon Richter Plc – Key news
Exhibits125: Gedeon Richter Plc – Key offerings
Exhibits126: Gedeon Richter Plc – Segment focus
Exhibits127: HLL Lifecare Ltd. – Overview
Exhibits128: HLL Lifecare Ltd. – Product / Service
Exhibits129: HLL Lifecare Ltd. – Key offerings
Exhibits130: Laboratoire HRA Pharma SAS – Overview
Exhibits131: Laboratoire HRA Pharma SAS – Product / Service
Exhibits132: Laboratoire HRA Pharma SAS – Key offerings
Exhibits133: Lupin Ltd. – Overview
Exhibits134: Lupin Ltd. – Product / Service
Exhibits135: Lupin Ltd. – Key news
Exhibits136: Lupin Ltd. – Key offerings
Exhibits137: Mankind Pharma Ltd. – Overview
Exhibits138: Mankind Pharma Ltd. – Product / Service
Exhibits139: Mankind Pharma Ltd. – Key offerings
Exhibits140: Perrigo Co. Plc – Overview
Exhibits141: Perrigo Co. Plc – Business segments
Exhibits142: Perrigo Co. Plc – Key news
Exhibits143: Perrigo Co. Plc – Key offerings
Exhibits144: Perrigo Co. Plc – Segment focus
Exhibits145: Pfizer Inc. – Overview
Exhibits146: Pfizer Inc. – Product / Service
Exhibits147: Pfizer Inc. – Key news
Exhibits148: Pfizer Inc. – Key offerings
Exhibits149: Piramal Enterprises Ltd. – Overview
Exhibits150: Piramal Enterprises Ltd. – Business segments
Exhibits151: Piramal Enterprises Ltd. – Key offerings
Exhibits152: Piramal Enterprises Ltd. – Segment focus
Exhibits153: Sun Pharmaceutical Industries Ltd. – Overview
Exhibits154: Sun Pharmaceutical Industries Ltd. – Product / Service
Exhibits155: Sun Pharmaceutical Industries Ltd. – Key offerings
Exhibits156: Syzygy Healthcare LLC – Overview
Exhibits157: Syzygy Healthcare LLC – Product / Service
Exhibits158: Syzygy Healthcare LLC – Key offerings
Exhibits159: Inclusions checklist
Exhibits160: Exclusions checklist
Exhibits161: Currency conversion rates for US$
Exhibits162: Research methodology
Exhibits163: Validation techniques employed for market sizing
Exhibits164: Information sources
Exhibits165: List of abbreviations

보고서 이미지

※본 조사보고서 [세계의 응급 피임약 시장 (2023~2027) : 소매점, 온라인 스토어] (코드 : IRTNTR70846-23) 판매에 관한 면책사항을 반드시 확인하세요.
※본 조사보고서 [세계의 응급 피임약 시장 (2023~2027) : 소매점, 온라인 스토어] 에 대해서 E메일 문의는 여기를 클릭하세요.

※당 사이트에 없는 보고서도 취급 가능한 경우가 많으니 문의 주세요!